abstract |
The present invention is based on the discovery that the administration of the protein NY-ESO-1, together with an adjuvant based on saponin makes it possible to obtain an unexpectedly strong immune response against cells expressing NY-ESO-1. Preferably, the combination is administered intramuscularly. |